CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies

Míreanna comhchosúla

• Author Correction: CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies
  de réir: Yongxian Hu, et al.
  Foilsithe / Cruthaithe: (2024-03-01)
• New-Onset Severe Cytopenia After CAR-T Cell Therapy: Analysis of 76 Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
  de réir: Linqin Wang, et al.
  Foilsithe / Cruthaithe: (2021-06-01)
• Successful BCMA CAR-T Therapy for Multiple Myeloma With Central Nervous System Involvement Manifesting as Cauda Equina Syndrome—A Wandering Road to Remission
  de réir: Yiyun Wang, et al.
  Foilsithe / Cruthaithe: (2021-11-01)
• Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies
  de réir: Linqin Wang, et al.
  Foilsithe / Cruthaithe: (2024-03-01)
• Cytokine release syndrome was an independent risk factor associated with hypoalbuminemia for patients with relapsed/refractory hematological malignancies after CAR-T cell therapy
  de réir: Shuyi Ding, et al.
  Foilsithe / Cruthaithe: (2023-11-01)